Quarterly ResultMay 5, 2026, 07:33 AM
Surgery Partners Q1 Revenue +4.5% to $810.9M; Net Loss $35.9M
AI Summary
Surgery Partners reported its first-quarter 2026 results, with revenue increasing 4.5% to $810.9 million and same-facility revenues growing 4.4%. The company posted a net loss attributable to Surgery Partners of $35.9 million and Adjusted EBITDA of $102.3 million. Management expressed encouragement with the solid start to 2026 and reaffirmed its full-year 2026 revenue guidance of $3.35 billion to $3.45 billion and Adjusted EBITDA of at least $530 million, citing confidence in returning to consistent growth.
Key Highlights
- Q1 2026 revenue increased 4.5% to $810.9 million.
- Same-facility revenues grew 4.4%, with same-facility cases up 0.6%.
- Net loss attributable to Surgery Partners was $35.9 million for the quarter.
- Adjusted EBITDA for Q1 2026 was $102.3 million.
- Reaffirmed full-year 2026 revenue guidance of $3.35 billion to $3.45 billion.
- Reaffirmed full-year 2026 Adjusted EBITDA guidance of at least $530 million.
- Cash flows from operating activities were $11.7 million, up from $6.0 million YoY.
- Total net debt to EBITDA ratio was approximately 4.3x at quarter-end.